Proteinuria: an enzymatic disease of the podocyte?

AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med (2013) 3.41

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19

Specialized roles for cysteine cathepsins in health and disease. J Clin Invest (2010) 2.69

The podocyte cytoskeleton--key to a functioning glomerulus in health and disease. Nat Rev Nephrol (2011) 1.86

Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest (2011) 1.81

Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int (2012) 1.66

A high-powered view of the filtration barrier. J Am Soc Nephrol (2010) 1.56

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46

Podocyte biology and pathogenesis of kidney disease. Annu Rev Med (2012) 1.32

Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney Int (2013) 1.27

Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med (2013) 1.22

Rac1 activation in podocytes induces rapid foot process effacement and proteinuria. Mol Cell Biol (2013) 1.19

New developments in steroid-resistant nephrotic syndrome. Pediatr Nephrol (2012) 1.18

Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol (2011) 1.08

Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology (2010) 1.03

Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2. Nephrol Dial Transplant (2011) 1.02

Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J Am Soc Nephrol (2012) 1.01

Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease. Nat Rev Nephrol (2013) 1.01

Podocyte GTPases regulate kidney filter dynamics. Kidney Int (2012) 0.96

Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev (2011) 0.94

Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest (2014) 0.94

HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor. Am J Physiol Renal Physiol (2013) 0.93

Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease. Nat Rev Nephrol (2015) 0.93

Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol (2011) 0.91

Understanding the mechanisms of proteinuria: therapeutic implications. Int J Nephrol (2012) 0.90

Protective effects of PPARγ agonist in acute nephrotic syndrome. Nephrol Dial Transplant (2011) 0.88

IQGAP1 interacts with components of the slit diaphragm complex in podocytes and is involved in podocyte migration and permeability in vitro. PLoS One (2012) 0.88

Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem (2012) 0.87

The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats. Exp Mol Med (2012) 0.86

Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury. Kidney Int (2015) 0.86

Minimal change disease as a modifiable podocyte paracrine disorder. Nephrol Dial Transplant (2011) 0.86

Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86

The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone/mineralocorticoid receptor-induced podocyte injury. Lab Invest (2015) 0.84

Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy. Adv Chronic Kidney Dis (2011) 0.84

Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy. Am J Pathol (2014) 0.83

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis. PLoS One (2015) 0.82

Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes. J Am Soc Nephrol (2014) 0.82

Establishment of protein delivery systems targeting podocytes. PLoS One (2010) 0.82

sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor. Sci Rep (2014) 0.82

Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. Biomed Res Int (2015) 0.82

Novel in vivo techniques to visualize kidney anatomy and function. Kidney Int (2015) 0.81

A compendium of urinary biomarkers indicative of glomerular podocytopathy. Patholog Res Int (2013) 0.81

Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) (2014) 0.81

Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol (2012) 0.81

Acute podocyte injury is not a stimulus for podocytes to migrate along the glomerular basement membrane in zebrafish larvae. Sci Rep (2017) 0.81

Podocytes. F1000Res (2016) 0.81

Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy. J Pathol (2015) 0.80

Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis. Pharmacoepidemiol Drug Saf (2016) 0.80

The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int J Nephrol (2014) 0.79

IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin. Cell Signal (2015) 0.79

Visualization of cytoskeletal dynamics in podocytes using adenoviral vectors. Cytoskeleton (Hoboken) (2014) 0.79

Myo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytes. PLoS One (2013) 0.79

Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. J Diabetes Res (2017) 0.78

Effects of melanocortin 1 receptor agonists in experimental nephropathies. PLoS One (2014) 0.78

Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation. Sci Rep (2015) 0.78

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury. Oncotarget (2015) 0.78

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep (2016) 0.77

Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol (2016) 0.77

Role of renal TRP channels in physiology and pathology. Semin Immunopathol (2015) 0.77

The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats. Oxid Med Cell Longev (2014) 0.77

Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Am J Physiol Renal Physiol (2016) 0.77

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy. J Pathol (2016) 0.77

Lipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway. Free Radic Biol Med (2015) 0.77

Nuclear hormone receptors in podocytes. Cell Biosci (2012) 0.77

Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med (2016) 0.76

1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria. PLoS One (2013) 0.76

Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury. Pediatr Nephrol (2012) 0.76

Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria. PLoS One (2016) 0.76

Visualization of podocyte substructure with structured illumination microscopy (SIM): a new approach to nephrotic disease. Biomed Opt Express (2016) 0.75

Disease-causing mutations of RhoGDIα induce Rac1 hyperactivation in podocytes. Small GTPases (2016) 0.75

Disease causing mutations in inverted formin 2 regulate its binding to G-actin, F-actin capping protein (CapZ α-1) and profilin 2. Biosci Rep (2016) 0.75

Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing. J Vet Med Sci (2016) 0.75

Recurrence and Treatment after Renal Transplantation in Children with FSGS. Biomed Res Int (2016) 0.75

Deletion of Rac1GTPase in the Myeloid Lineage Protects against Inflammation-Mediated Kidney Injury in Mice. PLoS One (2016) 0.75

Is the antiproteinuric effect of cyclosporine a independent of its immunosuppressive function in T cells? Int J Nephrol (2012) 0.75

RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal. BMC Nephrol (2016) 0.75

Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling. Am J Transl Res (2017) 0.75

Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis. Sci Rep (2017) 0.75

Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1. Sci Rep (2017) 0.75

Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy. JCI Insight (2017) 0.75

Rho GTPases in cell biology. Nature (2002) 22.81

Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77

VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00

Cell migration: Rho GTPases lead the way. Dev Biol (2004) 8.20

NFAT signaling: choreographing the social lives of cells. Cell (2002) 8.17

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science (2005) 7.03

The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int (2007) 6.99

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest (2003) 6.44

uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol (2002) 6.24

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet (2006) 5.29

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01

Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65

Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol (1997) 4.43

Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol (2007) 4.31

Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med (2006) 4.26

TGF-beta signaling in renal disease. J Am Soc Nephrol (2002) 4.21

Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development (1996) 4.20

Immunosuppressive drugs for kidney transplantation. N Engl J Med (2004) 4.09

Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature (2006) 4.05

Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet (1974) 4.02

Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01

NFATc1 balances quiescence and proliferation of skin stem cells. Cell (2008) 3.81

The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med (2008) 3.76

Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol (2008) 3.50

Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev (2008) 3.49

Progression of glomerular diseases: is the podocyte the culprit? Kidney Int (1998) 3.47

Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol (2006) 3.31

Podocyte biology and response to injury. J Am Soc Nephrol (2002) 3.25

Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest (2006) 3.23

The nephrotic syndrome. N Engl J Med (1998) 3.22

Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest (2008) 3.11

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes (2005) 3.10

Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell (2008) 3.09

Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int (2005) 3.09

The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol (2000) 2.99

Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature (2006) 2.96

Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82

Getting a foothold in nephrotic syndrome. Nat Genet (2000) 2.68

Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59

Glomerular epithelium: structural alterations induced by polycations. Science (1975) 2.59

A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell (2004) 2.44

Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest (2005) 2.39

Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest (2001) 2.36

Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32

The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet (1995) 2.30

Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest (2001) 2.26

Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol (2003) 2.25

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med (2008) 2.25

Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J Biol Chem (2003) 2.23

Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int (2004) 2.21

Ectopic notch activation in developing podocytes causes glomerulosclerosis. J Am Soc Nephrol (2008) 2.18

Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab Invest (1988) 2.16

Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol (2007) 2.13

Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin. J Biol Chem (2004) 2.10

Differentiation of epithelial foot processes and filtration slits: sequential appearance of occluding junctions, epithelial polyanion, and slit membranes in developing glomeruli. Lab Invest (1978) 2.07

Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest (2007) 2.04

Structure and function of podocytes: an update. Anat Embryol (Berl) (1995) 2.02

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest (2007) 2.02

Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93

Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene (1999) 1.91

Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol (2009) 1.86

Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol (2006) 1.85

Editorial: The primary glomerular filtration barrier--basement membrane or epithelial slits? Kidney Int (1975) 1.80

Glomerular permeability to macromolecules in the Necturus kidney. Am J Physiol Renal Physiol (2009) 1.80

Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J (2004) 1.73

Mice deficient in alpha-actinin-4 have severe glomerular disease. J Clin Invest (2003) 1.69

Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest (2006) 1.66

Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep (2004) 1.65

The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol (2001) 1.63

Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol (2004) 1.62

TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol (2005) 1.61

Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int (2005) 1.59

Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int Suppl (2004) 1.58

Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens (2001) 1.54

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. Am J Pathol (2005) 1.54

Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. J Am Soc Nephrol (2004) 1.52

Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli: the effects of low temperature, divalent cations, colchicine, and cytochalasin B. Lab Invest (1978) 1.47

Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med (Berl) (2008) 1.46

Classification of renal proteinuria: a simple algorithm. Clin Chem Lab Med (2002) 1.46

Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med (Berl) (1998) 1.45

Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol (2001) 1.41

Involvement of lipid rafts in nephrin phosphorylation and organization of the glomerular slit diaphragm. Am J Pathol (2001) 1.39

HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem (2008) 1.38

Glomerular sieving coefficient of serum albumin in the rat: a two-photon microscopy study. Am J Physiol Renal Physiol (2009) 1.37

Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol (2000) 1.37

KIBRA modulates directional migration of podocytes. J Am Soc Nephrol (2008) 1.36

The role of osteopontin in the development of albuminuria. J Am Soc Nephrol (2008) 1.33

Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012. J Clin Oncol (2008) 1.33

Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol (2004) 1.27

Disruption of Myosin 1e promotes podocyte injury. J Am Soc Nephrol (2008) 1.27

Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25

Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem (1997) 1.24

Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol (2001) 1.22

Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J (2001) 1.21

Nck links nephrin to actin in kidney podocytes. Cell (2006) 1.21

A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol (2002) 6.48

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01

Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2015) 4.85

Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19

Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83

Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest (2005) 2.39

Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet (2011) 2.38

Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol (2006) 2.32

COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21

Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. J Clin Invest (2007) 2.02

Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis. Transplantation (2012) 1.89

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol (2013) 1.83

Direct dynamin-actin interactions regulate the actin cytoskeleton. EMBO J (2010) 1.67

Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal (2011) 1.51

CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. J Clin Invest (2011) 1.49

Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation. Transplantation (2015) 1.47

A novel TRPC6 mutation that causes childhood FSGS. PLoS One (2009) 1.47

Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J Biol Chem (2008) 1.43

Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice. J Clin Invest (2010) 1.34

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int (2013) 1.33

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30

Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med (2014) 1.26

Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res (2010) 1.23

Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease. PLoS One (2010) 1.18

Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17

TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am J Physiol Renal Physiol (2010) 1.14

Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol (2014) 1.02

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) (2012) 1.02

Novel siRNA delivery system to target podocytes in vivo. PLoS One (2010) 0.96

Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol (2011) 0.96

Podocyte GTPases regulate kidney filter dynamics. Kidney Int (2012) 0.96

Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest (2014) 0.94

Sensitizing the Slit Diaphragm with TRPC6 ion channels. J Am Soc Nephrol (2008) 0.94

Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation (2013) 0.92

Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease. J Biol Chem (2013) 0.89

Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis (2012) 0.88

Role of podocytes in lupus nephritis. Nephrol Dial Transplant (2009) 0.88

The genetic basis of human glomerular disease. Adv Chronic Kidney Dis (2006) 0.87

Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release. Diabetes (2009) 0.87

Is there clinical value in measuring suPAR levels in FSGS? Clin J Am Soc Nephrol (2013) 0.87

Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis (2011) 0.86

Minimal change disease as a modifiable podocyte paracrine disorder. Nephrol Dial Transplant (2011) 0.86

TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease. Pediatr Nephrol (2010) 0.85

Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther (2013) 0.85

CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation. Nefrologia (2013) 0.83

Establishment of protein delivery systems targeting podocytes. PLoS One (2010) 0.82

C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells (2013) 0.82

In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma (Larchmt) (2011) 0.82

Filtering new facts about kidney disease. Nat Med (2011) 0.82

Leptin deficiency-induced obesity affects the density of mast cells in abdominal fat depots and lymph nodes in mice. Lipids Health Dis (2012) 0.81

Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant (2012) 0.81

BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization. J Pathol (2015) 0.80

Novel concepts in understanding and management of glomerular proteinuria. Nephrol Dial Transplant (2002) 0.80

Cellular effects of everolimus and sirolimus on podocytes. PLoS One (2013) 0.80

Enzymatic disease of the podocyte. Pediatr Nephrol (2010) 0.80

Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrol Dial Transplant (2012) 0.78

Circulating factor in FSGS: a black sheep in the suPAR family? Pediatr Nephrol (2013) 0.78

Regarding Maas's editorial letter on serum suPAR levels. Kidney Int (2012) 0.78

Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2016) 0.77

Maximal 'CD80-uria' with minimal change. Kidney Int (2010) 0.77

Fishing for new glomerular disease-related genes. J Am Soc Nephrol (2011) 0.76

Expression of trpC1 and trpC6 orthologs in zebrafish. Gene Expr Patterns (2008) 0.76

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response. Pediatr Nephrol (2014) 0.75

CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. J Clin Invest (2017) 0.75

TRPC6 in podocytes: questions and commentary on the article by Jiang et al., 'Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca21 and RhoA activation'. Exp Biol Med (Maywood) (2011) 0.75

An Interferon-Induced Digital Vasculitis-Like Syndrome: A Case Report. Am J Ther (2016) 0.75

Is podocyte research at a tipping point? Report from the 9(th) International Podocyte Conference. Kidney Int (2012) 0.75